COMMD10 and gastric adenocarcinoma: Kaplan–Meier survival analysis showed that high COMMD10 expression was associated with poor prognosis in STAD patients in terms of OS (HR = 1.7, p = 0.00093) and progression-free disease survival (HR = 1.8, p = 0.0025) (Figs. 3A, 3B).